{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:16:46Z","timestamp":1789010206886,"version":"build-2803163510"},"reference-count":24,"publisher":"Impact Journals, LLC","issue":"86","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,11,2]]},"DOI":"10.18632\/oncotarget.26242","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T15:18:31Z","timestamp":1541171911000},"page":"35611-35622","source":"Crossref","is-referenced-by-count":46,"title":["Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution"],"prefix":"10.18632","volume":"9","author":[{"given":"Joshua N.","family":"Kellner","sequence":"first","affiliation":[{"name":"Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline M.","family":"Delemarre","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology, University Medical Center Utrecht, Heidelberglaan, CX Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Yvon","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Nierkens","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Immunology, University Medical Center Utrecht, Heidelberglaan, CX Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap J.","family":"Boelens","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Stem Cell Transplant and Cellular Therapies, Memorial Sloan Kettering Cancer Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"McNiece","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Olson","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yago","family":"Nieto","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Ciurea","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Popat","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sairah","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Champlin","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ramos","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutaka","family":"Nishimoto","sequence":"additional","affiliation":[{"name":"Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbing","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"Ke","sequence":"additional","affiliation":[{"name":"Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Thall","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Khoury","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Negrin","sequence":"additional","affiliation":[{"name":"Division of Blood and Marrow Transplantation, Stanford University, Palo Alto, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borje","family":"Andersson","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simrit","family":"Parmar","sequence":"additional","affiliation":[{"name":"Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA"},{"name":"Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,11,2]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jcyt.2013.07.009","article-title":"Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease","volume":"16","author":"Najjar","year":"2014","journal-title":"Cytotherapy"},{"key":"2","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1182\/blood-2014-10-603449","article-title":"Ex vivo fucosylation of third-party human regulatory T cells enhances anti-graft-versus-host disease potency in vivo","volume":"125","author":"Shpall","year":"2015","journal-title":"Blood"},{"key":"3","doi-asserted-by":"publisher","first-page":"e89798","DOI":"10.1172\/jci.insight.89798","article-title":"An early-biomarker algorithm predicts lethal graft-versus-host disease and survival","volume":"2","author":"Qayed","year":"2017","journal-title":"JCI Insight"},{"key":"4","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics","volume":"117","author":"Wagner","year":"2011","journal-title":"Blood"},{"key":"5","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect","volume":"127","author":"Le","year":"2016","journal-title":"Blood"},{"key":"6","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bbmt.2013.01.014","article-title":"Pre-engraftment syndrome after unrelated cord blood transplantation: a predictor of engraftment and acute graft-versus-host disease","volume":"19","author":"Kim","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5045\/br.2016.51.3.152","article-title":"Pre-engraftment syndrome: clinical significance and pathophysiology","volume":"51","author":"Rah","year":"2016","journal-title":"Blood Res"},{"key":"8","doi-asserted-by":"publisher","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Ruggeri","year":"2011","journal-title":"Blood"},{"key":"9","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1182\/blood-2014-03-564401","article-title":"HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse","volume":"124","author":"Iacucci Ostini","year":"2014","journal-title":"Blood"},{"key":"10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.12659\/AOT.909122","article-title":"T Cell-Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation for Treatment of T-Lymphoblastic Lymphoma","volume":"23","author":"Wang","year":"2018","journal-title":"Ann Transplant"},{"key":"11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1365-2141.2012.09114.x","article-title":"What predicts high risk acute graft-versus-host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score","volume":"157","author":"Weisdorf","year":"2012","journal-title":"Br J Haematol"},{"key":"12","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/ctr.12268","article-title":"Limited benefit of pentostatin salvage therapy for steroid-refractory grade III-IV acute graft-versus-host disease","volume":"27","author":"Kuruvilla","year":"2013","journal-title":"Clin Transplant"},{"key":"13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/bjh.14433","article-title":"Increased regulatory T cell graft content is associated with improved outcome in haematopoietic stem cell transplantation: a systematic review","volume":"176","author":"Roberts","year":"2017","journal-title":"Br J Haematol"},{"key":"14","first-page":"1082","article-title":"IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation","volume":"83","author":"Gra\u00f1ena","year":"1998","journal-title":"Haematologica"},{"key":"15","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1182\/blood-2008-07-168419","article-title":"Paradoxical effects of IFN-gamma in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury","volume":"113","author":"Yang","year":"2009","journal-title":"Blood"},{"key":"16","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1016\/S2352-3026(14)00040-4","article-title":"Biomarkers for GVHD prognosis","volume":"2","author":"Pidala","year":"2015","journal-title":"Lancet Haematol"},{"key":"17","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/bmt.2012.143","article-title":"Biomarkers for acute GVHD: can we predict the unpredictable?","volume":"48","author":"Cutler","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1182\/blood-2014-11-611780","article-title":"ST2: the biomarker at the heart of GVHD severity","volume":"125","author":"Barrett","year":"2015","journal-title":"Blood"},{"key":"19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/bmt.2017.236","article-title":"Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402","volume":"53","author":"Weisdorf","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"20","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1182\/blood-2010-04-281659","article-title":"Blockade of osteopontin reduces alloreactive CD8+ T cell-mediated graft-versus-host disease","volume":"117","author":"Zhang","year":"2011","journal-title":"Blood"},{"key":"21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/tan.12090","article-title":"Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies","volume":"81","author":"Deeg","year":"2013","journal-title":"Tissue Antigens"},{"key":"22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Carbone","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a015552","article-title":"Regulatory T-cell therapy in transplantation: moving to the clinic","volume":"3","author":"Bluestone","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"24","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1158\/1078-0432.CCR-17-1597","article-title":"Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial","volume":"24","author":"Hamilton","year":"2018","journal-title":"Clin Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T19:51:19Z","timestamp":1589053879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,2]]},"references-count":24,"journal-issue":{"issue":"86","published-print":{"date-parts":[[2018,11,2]]}},"alternative-id":["26242","30479692"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.26242","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,2]]}}}